Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirum Pharmaceuticals, Inc. (MIRM) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mirum Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1759425.
Total stock buying since 2019: $118,186,326.
Total stock sales since 2019: $22,129,443.
Total stock option exercises since 2019: $944,731.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 6,364 | $280,429 | 187,395 | $8,483,819 | 236,581 | $308,266 |
| 2024 | 4,345 | $115,063 | 62,908 | $1,954,879 | 94,470 | $267,533 |
| 2023 | 169,053 | $4,519,467 | 68,970 | $1,919,115 | 48,929 | $136,016 |
| 2022 | 0 | $0 | 338,478 | $6,916,766 | 0 | $0 |
| 2021 | 8,450 | $121,305 | 176,299 | $2,854,864 | 1,082 | $8,331 |
| 2020 | 11,970 | $188,900 | 0 | $0 | 29,167 | $224,585 |
| 2019 | 7,539,397 | $112,961,162 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 1,041 | $50,624 | 1,041 | $0 |
| 2025-06 | 0 | $0 | 8,203 | $377,842 | 2,500 | $35,300 |
| 2025-05 | 0 | $0 | 0 | $0 | 34,218 | $0 |
| 2025-03 | 6,364 | $280,429 | 150,029 | $6,774,319 | 162,655 | $272,966 |
| 2025-01 | 0 | $0 | 28,122 | $1,281,034 | 36,167 | $0 |
| 2024-11 | 0 | $0 | 2,500 | $117,752 | 2,500 | $7,350 |
| 2024-09 | 345 | $13,863 | 0 | $0 | 18,334 | $0 |
| 2024-07 | 0 | $0 | 375 | $12,750 | 35,055 | $99,862 |
| 2024-06 | 0 | $0 | 35,559 | $1,167,406 | 35,559 | $160,321 |
| 2024-03 | 4,000 | $101,200 | 4,303 | $111,017 | 0 | $0 |
| 2024-02 | 0 | $0 | 10,599 | $277,607 | 0 | $0 |
| 2024-01 | 0 | $0 | 9,572 | $268,347 | 3,022 | $0 |
| 2023-12 | 0 | $0 | 2,500 | $81,000 | 2,500 | $7,350 |
| 2023-09 | 21,062 | $634,704 | 14,608 | $467,456 | 14,608 | $42,888 |
| 2023-08 | 147,991 | $3,884,763 | 3,459 | $90,743 | 0 | $0 |
| 2023-07 | 0 | $0 | 10,267 | $263,315 | 1,042 | $0 |
| 2023-06 | 0 | $0 | 14,608 | $423,632 | 16,171 | $42,889 |
| 2023-05 | 0 | $0 | 14,608 | $409,024 | 14,608 | $42,889 |
| 2023-01 | 0 | $0 | 8,920 | $183,945 | 0 | $0 |
| 2022-11 | 0 | $0 | 300,000 | $5,956,856 | 0 | $0 |
| 2022-06 | 0 | $0 | 38,478 | $959,910 | 0 | $0 |
| 2021-11 | 8,450 | $121,305 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 10,299 | $198,316 | 0 | $0 |
| 2021-07 | 0 | $0 | 166,000 | $2,656,548 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-03 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 477 | 49.08 | 23,411 |
| 2025-07-02 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 564 | 48.25 | 27,213 |
| 2025-07-01 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 1,041 | .00 | 0 |
| 2025-06-03 | Ramasastry Saira | Sale | 2,500 | 45.74 | 114,352 |
| 2025-06-03 | Ramasastry Saira | Option Ex | 2,500 | 14.12 | 35,300 |
| 2025-06-02 | Ramasastry Saira | Sale | 5,703 | 46.20 | 263,490 |
| 2025-05-29 | Cardon Lon | Option Ex | 5,703 | .00 | 0 |
| 2025-05-29 | Fairey William | Option Ex | 5,703 | .00 | 0 |
| 2025-05-29 | Ramasastry Saira | Option Ex | 5,703 | .00 | 0 |
| 2025-05-29 | Brege Laura | Option Ex | 5,703 | .00 | 0 |
| 2025-05-29 | Heron Patrick J | Option Ex | 5,703 | .00 | 0 |
| 2025-05-29 | Walbert Timothy P | Option Ex | 5,703 | .00 | 0 |
| 2025-03-18 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 2,415 | 44.45 | 107,341 |
| 2025-03-17 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 57,606 | 44.41 | 2,558,512 |
| 2025-03-17 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 52,900 | 2.94 | 155,526 |
| 2025-03-17 | Radovich Peter (PRESIDENT AND COO) | Sale | 7,879 | 44.21 | 348,362 |
| 2025-03-17 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Sale | 27,279 | 44.21 | 1,206,113 |
| 2025-03-17 | Heron Patrick J | Buy | 21 | 43.93 | 922 |
| 2025-03-15 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 5,315 | .00 | 0 |
| 2025-03-15 | Radovich Peter (PRESIDENT AND COO) | Option Ex | 14,440 | .00 | 0 |
| 2025-03-15 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Option Ex | 50,000 | .00 | 0 |
| 2025-03-14 | Heron Patrick J | Buy | 528 | 44.11 | 23,291 |
| 2025-03-11 | Heron Patrick J | Buy | 963 | 43.77 | 42,155 |
| 2025-03-10 | Heron Patrick J | Buy | 1,335 | 43.02 | 57,426 |
| 2025-03-07 | Heron Patrick J | Buy | 580 | 43.22 | 25,064 |
| 2025-03-06 | Heron Patrick J | Buy | 1,335 | 43.89 | 58,597 |
| 2025-03-05 | Heron Patrick J | Buy | 267 | 44.55 | 11,893 |
| 2025-03-04 | Radovich Peter (PRESIDENT AND COO) | Sale | 14,850 | 45.66 | 677,991 |
| 2025-03-04 | Heron Patrick J | Buy | 1,335 | 45.75 | 61,081 |
| 2025-03-03 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Sale | 40,000 | 46.90 | 1,876,000 |
| 2025-03-03 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Option Ex | 40,000 | 2.94 | 117,440 |
| 2025-01-24 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 902 | 47.92 | 43,227 |
| 2025-01-24 | Radovich Peter (PRESIDENT AND COO) | Sale | 3,177 | 47.92 | 152,257 |
| 2025-01-24 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Sale | 6,837 | 47.92 | 327,656 |
| 2025-01-23 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 1,500 | .00 | 0 |
| 2025-01-23 | Radovich Peter (PRESIDENT AND COO) | Option Ex | 5,750 | .00 | 0 |
| 2025-01-23 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,500 | .00 | 0 |
| 2025-01-23 | Bjerkholt Eric (CHIEF FINANCIAL OFFICER) | Option Ex | 2,667 | .00 | 0 |
| 2025-01-17 | Quan Joanne (CHIEF MEDICAL OFFICER) | Sale | 6,969 | 45.86 | 319,598 |
| 2025-01-16 | Quan Joanne (CHIEF MEDICAL OFFICER) | Option Ex | 12,500 | .00 | 0 |
| 2025-01-07 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 750 | 42.81 | 32,111 |
| 2025-01-07 | Radovich Peter (PRESIDENT AND COO) | Sale | 1,998 | 42.81 | 85,544 |
| 2025-01-07 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Sale | 7,489 | 42.81 | 320,641 |
| 2025-01-06 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 1,250 | .00 | 0 |
| 2024-11-14 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 2,500 | 47.10 | 117,752 |
| 2024-11-14 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 2,500 | 2.94 | 7,350 |
| 2024-09-18 | Heron Patrick J | Buy | 115 | 37.40 | 4,301 |
| 2024-09-11 | Bjerkholt Eric (CHIEF FINANCIAL OFFICER) | Option Ex | 18,334 | .00 | 0 |
| 2024-09-06 | Heron Patrick J | Buy | 230 | 41.58 | 9,562 |
| 2024-07-23 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Option Ex | 34,013 | 2.94 | 99,862 |
| 2024-07-02 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 375 | 34.00 | 12,750 |
| 2024-07-01 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 1,042 | .00 | 0 |
| 2024-06-24 | Vig Pamela (CHIEF SCIENTIFIC OFFICER) | Sale | 30,559 | 34.00 | 1,039,006 |
| 2024-06-24 | Vig Pamela (CHIEF SCIENTIFIC OFFICER) | Option Ex | 30,559 | 2.94 | 89,721 |
| 2024-06-05 | Ramasastry Saira | Sale | 5,000 | 25.68 | 128,400 |
| 2024-06-05 | Ramasastry Saira | Option Ex | 5,000 | 14.12 | 70,600 |
| 2024-03-27 | Bjerkholt Eric (CHIEF FINANCIAL OFFICER) | Buy | 2,000 | 24.80 | 49,600 |
| 2024-03-25 | Radovich Peter (PRESIDENT AND COO) | Sale | 4,303 | 25.80 | 111,017 |
| 2024-03-18 | Bjerkholt Eric (CHIEF FINANCIAL OFFICER) | Buy | 2,000 | 25.80 | 51,600 |
| 2024-02-02 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 735 | 26.19 | 19,251 |
| 2024-02-02 | Longpre Lara (CHIEF DEVELOPMENT OFFICER) | Sale | 847 | 26.19 | 22,184 |
| 2024-02-02 | Vig Pamela (CHIEF SCIENTIFIC OFFICER) | Sale | 1,214 | 26.19 | 31,797 |
| 2024-02-02 | Radovich Peter (PRESIDENT AND COO) | Sale | 1,790 | 26.19 | 46,883 |
| 2024-02-02 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Sale | 6,013 | 26.19 | 157,492 |
| 2024-01-31 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 1,772 | .00 | 0 |
| 2024-01-08 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Sale | 528 | 28.04 | 14,802 |
| 2024-01-08 | Longpre Lara (CHIEF DEVELOPMENT OFFICER) | Sale | 1,019 | 28.04 | 28,567 |
| 2024-01-08 | Vig Pamela (HEAD OF RESEARCH & DEVELOPMENT) | Sale | 1,408 | 28.03 | 39,471 |
| 2024-01-08 | Radovich Peter (CHIEF OPERATING OFFICER) | Sale | 1,408 | 28.04 | 39,473 |
| 2024-01-08 | Peetz Christopher (PRESIDENT AND CEO) | Sale | 5,209 | 28.04 | 146,034 |
| 2024-01-06 | Howe Jolanda (SVP, GLOBAL CONTROLLER) | Option Ex | 1,250 | .00 | 0 |
| 2023-12-05 | Howe Jolanda (SVP, Global Controller) | Sale | 2,500 | 32.40 | 81,000 |
| 2023-12-05 | Howe Jolanda (SVP, Global Controller) | Option Ex | 2,500 | 2.94 | 7,350 |
| 2023-09-14 | Grey Michael G (Director) | Sale | 14,216 | 32.00 | 454,912 |
| 2023-09-14 | Grey Michael G (Director) | Option Ex | 14,216 | 2.94 | 41,738 |
| 2023-09-13 | Heron Patrick J (Director) | Buy | 2,625 | 31.02 | 81,424 |
| 2023-09-13 | Grey Michael G (Director) | Sale | 392 | 32.00 | 12,544 |
| 2023-09-13 | Grey Michael G (Director) | Option Ex | 392 | 2.94 | 1,150 |
| 2023-09-12 | Heron Patrick J (Director) | Buy | 3,750 | 30.60 | 114,765 |
| 2023-09-11 | Heron Patrick J (Director) | Buy | 4,687 | 30.30 | 142,025 |
| 2023-09-11 | Bjerkholt Eric (Chief Financial Officer) | Buy | 10,000 | 29.65 | 296,490 |
| 2023-08-31 | Heron Patrick J (Director) | Buy | 147,991 | 26.25 | 3,884,763 |
| 2023-08-25 | Howe Jolanda (SVP, Global Controller) | Sale | 3,459 | 26.23 | 90,743 |
| 2023-07-03 | Howe Jolanda (SVP, Global Controller) | Sale | 915 | 25.65 | 23,467 |
| 2023-07-03 | Longpre Lara (Chief Development Officer) | Sale | 1,004 | 25.65 | 25,749 |
| 2023-07-03 | Vig Pamela (Head of Research & Development) | Sale | 1,425 | 25.65 | 36,546 |
| 2023-07-03 | Radovich Peter (Chief Operating Officer) | Sale | 1,425 | 25.65 | 36,546 |
| 2023-07-03 | Peetz Christopher (President and CEO) | Sale | 5,498 | 25.65 | 141,007 |
| 2023-07-01 | Howe Jolanda (SVP, Global Controller) | Option Ex | 1,042 | .00 | 0 |
| 2023-06-30 | Howe Jolanda (SVP, Global Controller) | Option Ex | 1,563 | .00 | 0 |
| 2023-06-08 | Grey Michael G (Director) | Sale | 14,608 | 29.00 | 423,632 |
| 2023-06-08 | Grey Michael G (Director) | Option Ex | 14,608 | 2.94 | 42,889 |
| 2023-05-03 | Grey Michael G (Director) | Sale | 14,608 | 28.00 | 409,024 |
| 2023-05-03 | Grey Michael G (Director) | Option Ex | 14,608 | 2.94 | 42,889 |
| 2023-01-09 | Longpre Lara (CHIEF DEVELOPMENT OFFICER) | Sale | 1,003 | 20.62 | 20,683 |
| 2023-01-09 | Vig Pamela (CHIEF SCIENTIFIC OFFICER) | Sale | 1,379 | 20.62 | 28,437 |
| 2023-01-09 | Radovich Peter (PRESIDENT AND COO) | Sale | 1,379 | 20.62 | 28,437 |
| 2023-01-09 | Peetz Christopher (CHIEF EXECUTIVE OFFICER) | Sale | 5,159 | 20.62 | 106,388 |
| 2022-11-15 | O'donnell Niall (Director) | Sale | 93,770 | 19.69 | 1,846,049 |
| 2022-11-14 | O'donnell Niall (Director) | Sale | 32,109 | 19.60 | 629,432 |
| 2022-11-11 | O'donnell Niall (Director) | Sale | 174,121 | 19.99 | 3,481,375 |
| 2022-06-06 | Deerfield Healthcare Innovations Fund, L.p. | Sale | 38,478 | 24.95 | 959,910 |
| 2021-11-26 | Clements Ian (Chief Financial Officer) | Buy | 750 | 13.90 | 10,425 |
| 2021-11-24 | Clements Ian (Chief Financial Officer) | Buy | 700 | 14.40 | 10,080 |
| 2021-11-24 | Peetz Christopher (President and CEO) | Buy | 7,000 | 14.40 | 100,800 |
| 2021-10-01 | Tucker Edwin Jonathan (Chief Medical Officer) | Sale | 1,364 | 19.26 | 26,265 |
| 2021-10-01 | Longpre Lara (Chief Development Officer) | Sale | 961 | 19.26 | 18,505 |
| 2021-10-01 | Clements Ian (Chief Financial Officer) | Sale | 1,574 | 19.26 | 30,308 |
| 2021-10-01 | Vig Pamela (Chief Scientific Officer) | Sale | 1,364 | 19.26 | 26,265 |
| 2021-10-01 | Radovich Peter (Chief Operating Officer) | Sale | 1,364 | 19.26 | 26,265 |
| 2021-10-01 | Peetz Christopher (President and CEO) | Sale | 3,672 | 19.26 | 70,708 |
| 2021-07-09 | Deerfield Special Situations Fund, L.p. | Sale | 99,325 | 15.81 | 1,570,328 |
| 2021-07-07 | Deerfield Special Situations Fund, L.p. | Sale | 6,837 | 15.87 | 108,496 |
| 2021-07-06 | Deerfield Special Situations Fund, L.p. | Sale | 49,239 | 16.20 | 797,425 |
| 2021-07-02 | Deerfield Special Situations Fund, L.p. | Sale | 10,599 | 17.01 | 180,299 |
| 2021-03-05 | Tucker Edwin Jonathan (Chief Medical Officer) | Option Ex | 1,082 | 7.70 | 8,331 |
| 2020-12-28 | Tucker Edwin Jonathan (Chief Medical Officer) | Option Ex | 4,167 | 7.70 | 32,085 |
| 2020-12-23 | Clements Ian (Chief Financial Officer) | Buy | 2,470 | 18.60 | 45,942 |
| 2020-12-23 | Peetz Christopher (President and CEO) | Buy | 5,000 | 18.68 | 93,400 |
| 2020-10-30 | Tucker Edwin Jonathan (Chief Medical Officer) | Option Ex | 25,000 | 7.70 | 192,500 |
| 2020-03-20 | Tucker Edwin Jonathan (Chief Medical Officer) | Buy | 2,500 | 11.90 | 29,740 |
| 2020-03-19 | Tucker Edwin Jonathan (Chief Medical Officer) | Buy | 2,000 | 9.91 | 19,818 |
| 2019-09-17 | Fischer Laurent (Director) | Buy | 1,648 | 9.37 | 15,435 |
| 2019-09-16 | Fischer Laurent (Director) | Buy | 452 | 9.47 | 4,280 |
| 2019-09-10 | Longpre Lara (CHIEF DEVELOPMENT OFFICER) | Buy | 965 | 10.64 | 10,267 |
| 2019-09-10 | Fischer Laurent (Director) | Buy | 960 | 10.29 | 9,881 |
| 2019-09-10 | Brege Laura (Director) | Buy | 10,000 | 11.22 | 112,200 |
| 2019-09-09 | Peetz Christopher (President and CEO) | Buy | 4,320 | 11.12 | 48,060 |
| 2019-09-09 | Fischer Laurent (Director) | Buy | 1,970 | 10.92 | 21,512 |
| 2019-09-06 | Clements Ian (SVP Finance & Communications) | Buy | 4,000 | 11.47 | 45,880 |
| 2019-09-06 | Vig Pamela (Chief Scientific Officer) | Buy | 1,612 | 11.42 | 18,410 |
| 2019-09-06 | Peetz Christopher (President and CEO) | Buy | 4,750 | 10.91 | 51,808 |
| 2019-09-06 | Fischer Laurent (Director) | Buy | 1,720 | 10.71 | 18,429 |
| 2019-07-22 | O'donnell Niall (Director) | Buy | 300,000 | 15.00 | 4,500,000 |
| 2019-07-22 | Chang Carmen (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Nea 16 Gp, Llc (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Makhzoumi Mohamad (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Behbahani Ali (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Florence Anthony A. Jr. (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Sonsini Peter W. (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Walker Paul Edward (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Novo Holdings A/s (10% Owner) | Buy | 575,000 | 15.00 | 8,625,000 |
| 2019-07-22 | Heron Patrick J (Director) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Deerfield Special Situations Fund, L.p. | Buy | 332,000 | 15.00 | 4,980,000 |
| 2019-07-22 | Topper James N (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Baskett Forest (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Sandell Scott D (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Makower Joshua (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Mott David M (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2019-07-22 | Barris Peter J (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of MIRM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mirum Pharmaceuticals, Inc. (symbol MIRM, CIK number 1759425) see the Securities and Exchange Commission (SEC) website.